Cargando…
Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?
Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et al.
Autor principal: | Santamaria, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326129/ https://www.ncbi.nlm.nih.gov/pubmed/34345206 http://dx.doi.org/10.7150/ijbs.63969 |
Ejemplares similares
-
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
por: Martorana, Federica, et al.
Publicado: (2021) -
Cyclosporine: an old weapon in the fight against coronaviruses
por: Molyvdas, Adam, et al.
Publicado: (2020) -
Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021) -
Probiotics as a Weapon in the Fight Against COVID-19
por: Stavropoulou, Elisavet, et al.
Publicado: (2020) -
New Antibody Weapons against an Old Foe
por: Benach, Jorge L.
Publicado: (2011)